In 2022, Yiling Pharmaceutical made more than half of its revenue from medications treating respiratory diseases. Meanwhile, cardiovascular and cerebrovascular products remained an important source of revenue. The company became highly profitable since the start of the *** pandemic when its traditional Chinese medicine product Lianhua Qingwen gained national popularity.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Yiling Pharmaceutical. (April 26, 2023). Revenue share of Yiling Pharmaceutical Co., Ltd. in 2022, by product segment [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 25, 2026, from /statistics/1392650/yiling-pharmaceutical-revenue-share-by-product-segment/
Yiling Pharmaceutical. "Revenue share of Yiling Pharmaceutical Co., Ltd. in 2022, by product segment." Chart. April 26, 2023. ÌÇÐÄÆÆ½â°æ. Accessed July 25, 2026. /statistics/1392650/yiling-pharmaceutical-revenue-share-by-product-segment/
Yiling Pharmaceutical. (2023). Revenue share of Yiling Pharmaceutical Co., Ltd. in 2022, by product segment. ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 25, 2026. /statistics/1392650/yiling-pharmaceutical-revenue-share-by-product-segment/
Yiling Pharmaceutical. "Revenue Share of Yiling Pharmaceutical Co., Ltd. in 2022, by Product Segment." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 26 Apr 2023, /statistics/1392650/yiling-pharmaceutical-revenue-share-by-product-segment/
Yiling Pharmaceutical, Revenue share of Yiling Pharmaceutical Co., Ltd. in 2022, by product segment ÌÇÐÄÆÆ½â°æ, /statistics/1392650/yiling-pharmaceutical-revenue-share-by-product-segment/ (last visited July 25, 2026)
Revenue share of Yiling Pharmaceutical Co., Ltd. in 2022, by product segment [Graph], Yiling Pharmaceutical, April 26, 2023. [Online]. Available: /statistics/1392650/yiling-pharmaceutical-revenue-share-by-product-segment/